Clinical Trial Update: Theophylline Effects in the Fontan Circulation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing theophylline effects in individuals with Fontan circulation due to congenital heart disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Fontan Circulation

Drugs mentioned

• Theophylline (Theophylline)

Snippet

Sponsor: Oslo University Hospital | Conditions: Congenital Heart Disease | Phase 2 | Status: COMPLETED